Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors
Authors:
- Wei ZhengWZWei Zheng
- Liyun JiLJLiyun Ji
- Qun LuoQLQun Luo
- Xiang HaoXHXiang Hao
- Xianchan LiXLXianchan Li
- Fuyi WangFWFuyi Wang
- 1 March 2013
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 61, 84-94
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Mass spectrometry-based biochemical assays for enzyme-inhibitor screeningTrAC Trends in Analytical Chemistry, 2007
- ErbB receptors: from oncogenes to targeted cancer therapiesJournal of Clinical Investigation, 2007
- Receptor–ligand binding assays: Technologies and ApplicationsJournal of Chromatography B, 2005
- Labeling strategies for bioassaysAnalytical and Bioanalytical Chemistry, 2005
- Novel detection strategies for drug discoveryDrug Discovery Today, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitorProceedings of the National Academy of Sciences, 1998
- Epidermal growth factor-related peptides and their receptors in human malignanciesCritical Reviews in Oncology/Hematology, 1995
- A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine KinaseScience, 1994
- Development of solid-phase enzyme-linked immunosorbent assays for the determination of epidermal growth factor receptor and pp60c-src tyrosine protein kinase activityAnalytical Biochemistry, 1992